The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Osteoporosis and Schizophrenia

To the Editor:

Martina Hummer, M.D., et al. (1) reported the occurrence of low bone mineral density in a group of young male subjects with schizophrenia. Levine et al. (2) and Applebaum et al. (3) reported elevated plasma homocysteine levels in young male schizophrenic patients.

Elevated homocysteine plasma levels were recently reported to be associated with osteoporotic bone fractures in the elderly in two large follow-up studies (4, 5). McLean et al. (4) analyzed blood samples obtained and stored from 1,999 men and women as part of the long-term Framingham Study. These researchers found that men and women in the upper quartile of homocysteine concentrations were nearly four and two times, respectively, as likely to later have a hip fracture in comparison to the lower quartile of homocysteine concentrations. Van Meurs et al. (5) analyzed blood samples and health data from 2,406 people. Men and women in the upper quartile of homocysteine concentrations were about twice as likely to have a hip or other bone fracture as were those in the lower quartile of homocysteine concentrations.

The mechanism underlying homocysteine’s effect on bone metabolism is not yet clear. However, several mechanisms were suggested, including that elevated homocysteine disturbs the cross-linking of collagen in bone and disturbs osteoblast formation (6).

Thus, it is suggested that elevated homocysteine levels may be a mechanism of the low bone mineral density reported by Dr. Hummer et al. (1) among young male subjects suffering from schizophrenia.

References

1. Hummer M, Malik P, Gasser RW, Hofer A, Kemmler G, Naveda RCM, Rettenbacher MA, Fleischhacker WW: Osteoporosis in patients with schizophrenia. Am J Psychiatry 2005; 162:162–167LinkGoogle Scholar

2. Levine J, Stahl Z, Ami B, Slava S, Ruderman GV, Belmaker RH: Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry 2002; 159:1790–1792LinkGoogle Scholar

3. Applebaum J, Shimon H, Sela BA, Belmaker RH, Levine J: Homocysteine levels in newly admitted schizophrenic patients. J Psychiatr Res 2004; 38:413–416Crossref, MedlineGoogle Scholar

4. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP: Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004; 350:2042–2049Crossref, MedlineGoogle Scholar

5. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG: Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004; 350:2033–2041Crossref, MedlineGoogle Scholar

6. Krumdieck CL, Prince CW: Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of aging. J Nutr 2000; 130(2S suppl):365S-368SGoogle Scholar